If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
48.50    0.00 (0.00%)
Bid:
48.00
Ask:
49.00
Spread: 1.00 (2.083%)
Market Cap: £7.38m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

Board Changes

Today 07:00

RNS Number : 2289L
Transense Technologies PLC
07 July 2026
 

7 July 2026

Transense Technologies plc

("Transense" or the "Company")

Board Changes

Retirement of Chief Financial Officer and Appointment of Finance Director (designate)

Transense Technologies plc (AIM: TRT), the provider of specialist sensor technology and measurement solutions, announces that Melvyn Segal has informed the Board of his intention to retire from the role of Chief Financial Officer ("CFO") and Company Secretary with effect from the Company's Annual General Meeting (AGM) in November 2026. The Board also announces the appointment of Richard Michael Pearce ACA as Finance Director with effect from 1 September 2026.

Melvyn will remain with the Company in an executive capacity for a handover period until the AGM, and will subsequently remain on the Board as a non-executive director for a further year. The Board would like to thank Melvyn for his significant contribution to Transense over many years, during which the Company and its prospects have been transformed.

Richard brings over twenty years of financial, commercial and listed company experience to Transense. Since qualifying as a Chartered Accountant with Ernst & Young in 1999, he has held senior finance roles at GE Healthcare and TD Williamson, and most recently as Finance Director at Lombard Medical where he oversaw a scale-up in revenues from £6m to £25m per annum since 2018. He will initially work alongside Melvyn in a non-board role as Finance Director, with progression to the Board leading the Group's finance function when Melvyn's steps down as CFO in November 2026.

The Board welcomes Richard to his new role and we look forward to his contribution to delivery of the future growth strategy.

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Ryan Maughan (Managing Director)

Melvyn Segal (Chief Financial Officer)

Via Investor Relations

(see below)

Cavendish Capital Market Limited (Nominated Adviser and Broker)

Adrian Hadden / Callum Davidson (Corporate Finance)

Jasper Berry (Sales)

0207 220 0500

Investor Relations

Anice McNamee

Tel: +44 (0)1869 238380

Investor.relations@transense.co.uk

Notes to Editors:

Transense is headquartered in Oxfordshire, UK and its shares are traded on AIM, a market operated by the London Stock Exchange (AIM: TRT). The Company develops and supplies advanced sensor technology and measurement solutions used by some of the world's leading companies to improve performance, efficiency, and safety in demanding, mission critical applications. Transense currently operates through two active business segments:

· SAWsense - designs, supplies and licences advanced sensor solutions based on proven, patent protected Surface Acoustic Wave (SAW) technology to world leading companies in aerospace, automotive, and industrial machinery (including robotics), enabling improved efficiency and performance of their products. Key customers include GE Aerospace, Parker Meggitt, McLaren Applied, Airbus and several other confidential Tier One automotive, aerospace and industrial machinery suppliers.

 

· Translogik - develops smart, connected commercial vehicle tyre inspection equipment to many of the world's leading tyre suppliers, fleet operators and service centres. Enabling accurate measurement and digital capture of safety-critical tyre condition data, used to reduce operating costs, improve safety and provide audit records for regulatory compliance. Key customers include Bridgestone, Goodyear, Continental and Prometeon (Pirelli), and leading independent providers of vehicle fleet maintenance management software.

 In addition, Transense earns residual royalty income from Bridgestone iTrack - a tyre monitoring system for off-highway vehicles that was developed by Translogik. The associated sales, support and development infrastructure were sold to Bridgestone Corporation, the world's largest tyre producer, in June 2020, and the intellectual property was licensed exclusively to Bridgestone under a ten-year deal expiring in 2030.

Find out more at: https://www.transense.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAAKABQCBKDDOK
Date   Source Headline
7th Mar 20147:00 amRNSExercise of Warrants
3rd Mar 201411:00 amRNSHolding(s) in Company
25th Feb 20141:55 pmRNSDirector Dealing
21st Feb 201412:40 pmRNSExercise of Warrants
5th Feb 20146:20 pmRNSExercise of Warrants
5th Feb 20147:00 amRNSAward of Options
4th Feb 20147:00 amRNSInterim Results
7th Nov 20136:28 pmRNSExercise of Warrants
29th Oct 20133:25 pmRNSHolding(s) in Company
11th Oct 20134:05 pmRNSResult of AGM
11th Oct 20137:00 amRNSAGM Statement and Directorate Change
7th Oct 201312:06 pmRNSHolding(s) in Company
20th Sep 20139:54 amRNSDirector/PDMR Shareholding
19th Sep 20139:41 amRNSExercise of Warrants
17th Sep 20133:54 pmRNSPosting of Accounts and Notice of AGM
16th Sep 20137:00 amRNSFinal Results
3rd Sep 20134:20 pmRNSHolding(s) in Company
27th Aug 20137:00 amRNSMajor iTrack Order from Otraco in Chile
20th Aug 20135:52 pmRNSExercise of Warrants and Exercise of Options
1st Aug 20135:40 pmRNSExercise of Warrants
1st Aug 20137:00 amRNSTrading Update and Notice of Results
30th Jul 20135:30 pmRNSIssue of Equity
11th Jul 20134:46 pmRNSOffer, Further Placing and Exercise of Options
8th Jul 201312:14 pmRNSHolding(s) in Company
2nd Jul 201312:27 pmRNSResult of General Meeting
2nd Jul 20137:00 amRNSGeneral Meeting Statement
13th Jun 20132:45 pmRNSHolding(s) in Company
12th Jun 20132:10 pmRNSHolding(s) in Company
10th Jun 20137:00 amRNSCompletion of First Placing & Exercise of Warrants
7th Jun 20137:01 amRNSPlacing and Offer for Subscription
7th Jun 20137:00 amRNSMajor iTrack Contract with Anglo American
28th May 201310:26 amRNSIntelliSAW order from partner ETT worth US$450,000
28th May 20137:00 amRNSTranslogik Probe Order From Dunlop Japan
13th May 20137:00 amRNSTranslogik two largest probe orders
10th May 20136:10 pmRNSExercise of Warrants
17th Apr 20134:00 pmRNSExercise of Warrants
15th Apr 201310:40 amRNSHolding(s) in Company
28th Mar 201312:21 pmRNSIssue of Equity
28th Mar 201312:20 pmRNSInterim Results
5th Mar 20137:00 amRNSIntelliSAW Update
15th Feb 20133:00 pmRNSExercise of Warrants
7th Feb 201311:00 amRNSExercise of Warrants
16th Jan 20134:05 pmRNSExercise of Warrants
30th Nov 20124:05 pmRNSTotal Voting Rights
27th Nov 20125:30 pmRNSExercise of Warrants
20th Nov 20123:05 pmRNSExercise of Warrants
8th Nov 20127:00 amRNSAppointment as Sole Broker
29th Oct 20125:00 pmRNSResult of AGM
29th Oct 20124:10 pmRNSReplacement: Change of Name of Nominated Adviser
29th Oct 20127:00 amRNSChange of name of Nominated Adviser & Joint Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.